Thomas Y, Androphy E
J Virol. 2019; 93(7).
PMID: 30651357
PMC: 6430547.
DOI: 10.1128/JVI.02224-18.
Kanginakudru S, DeSmet M, Thomas Y, Morgan I, Androphy E
Virology. 2015; 478:129-35.
PMID: 25666521
PMC: 4361275.
DOI: 10.1016/j.virol.2015.01.011.
Archambault J, Melendy T
Antivir Ther. 2013; 18(3):271-83.
PMID: 23615820
PMC: 4658057.
DOI: 10.3851/IMP2612.
Gagnon D, Senechal H, DAbramo C, Alvarez J, McBride A, Archambault J
Virology. 2013; 439(2):132-9.
PMID: 23490049
PMC: 4654618.
DOI: 10.1016/j.virol.2013.02.012.
Quinlan E, Culleton S, Wu S, Chiang C, Androphy E
J Virol. 2012; 87(3):1497-507.
PMID: 23152516
PMC: 3554136.
DOI: 10.1128/JVI.02771-12.
Proteasomal degradation of the papillomavirus E2 protein is inhibited by overexpression of bromodomain-containing protein 4.
Gagnon D, Joubert S, Senechal H, Fradet-Turcotte A, Torre S, Archambault J
J Virol. 2009; 83(9):4127-39.
PMID: 19211738
PMC: 2668459.
DOI: 10.1128/JVI.02468-08.
Dual roles of an essential cysteine residue in activity of a redox-regulated bacterial transcriptional activator.
Gupta N, Ragsdale S
J Biol Chem. 2008; 283(42):28721-8.
PMID: 18687692
PMC: 2568902.
DOI: 10.1074/jbc.M800630200.
Mitotic kinesin-like protein 2 binds and colocalizes with papillomavirus E2 during mitosis.
Yu T, Peng Y, Androphy E
J Virol. 2006; 81(4):1736-45.
PMID: 17135315
PMC: 1797594.
DOI: 10.1128/JVI.01638-06.
Bromodomain protein 4 mediates the papillomavirus E2 transcriptional activation function.
Schweiger M, You J, Howley P
J Virol. 2006; 80(9):4276-85.
PMID: 16611886
PMC: 1472042.
DOI: 10.1128/JVI.80.9.4276-4285.2006.
Conditional mutations in the mitotic chromosome binding function of the bovine papillomavirus type 1 E2 protein.
Zheng P, Brokaw J, McBride A
J Virol. 2005; 79(3):1500-9.
PMID: 15650176
PMC: 544132.
DOI: 10.1128/JVI.79.3.1500-1509.2005.
Analysis of chromatin attachment and partitioning functions of bovine papillomavirus type 1 E2 protein.
Abroi A, Ilves I, Kivi S, Ustav M
J Virol. 2004; 78(4):2100-13.
PMID: 14747575
PMC: 369436.
DOI: 10.1128/jvi.78.4.2100-2113.2004.
A transactivator function of cottontail rabbit papillomavirus e2 is essential for tumor induction in rabbits.
Jeckel S, Huber E, Stubenrauch F, Iftner T
J Virol. 2002; 76(22):11209-15.
PMID: 12388680
PMC: 136747.
DOI: 10.1128/jvi.76.22.11209-11215.2002.
Papillomavirus E1 proteins: form, function, and features.
Wilson V, West M, Woytek K, Rangasamy D
Virus Genes. 2002; 24(3):275-90.
PMID: 12086149
DOI: 10.1023/a:1015336817836.
AMF-1/Gps2 binds p300 and enhances its interaction with papillomavirus E2 proteins.
Peng Y, Breiding D, Sverdrup F, Richard J, Androphy E
J Virol. 2000; 74(13):5872-9.
PMID: 10846067
PMC: 112082.
DOI: 10.1128/jvi.74.13.5872-5879.2000.
Mechanisms of human papillomavirus E2-mediated repression of viral oncogene expression and cervical cancer cell growth inhibition.
Nishimura A, Ono T, Ishimoto A, Dowhanick J, Frizzell M, Howley P
J Virol. 2000; 74(8):3752-60.
PMID: 10729150
PMC: 111884.
DOI: 10.1128/jvi.74.8.3752-3760.2000.
Role of the ATP-binding domain of the human papillomavirus type 11 E1 helicase in E2-dependent binding to the origin.
Titolo S, Pelletier A, Sauve F, Brault K, Wardrop E, White P
J Virol. 1999; 73(7):5282-93.
PMID: 10364274
PMC: 112583.
DOI: 10.1128/JVI.73.7.5282-5293.1999.
Effect of bovine papillomavirus E2 protein-specific monoclonal antibodies on papillomavirus DNA replication.
Kurg R, Parik J, Juronen E, Sedman T, Abroi A, Liiv I
J Virol. 1999; 73(6):4670-7.
PMID: 10233926
PMC: 112508.
DOI: 10.1128/JVI.73.6.4670-4677.1999.
A fifteen-amino-acid peptide inhibits human papillomavirus E1-E2 interaction and human papillomavirus DNA replication in vitro.
Kasukawa H, Howley P, Benson J
J Virol. 1998; 72(10):8166-73.
PMID: 9733858
PMC: 110160.
DOI: 10.1128/JVI.72.10.8166-8173.1998.
Transactivation by the E2 protein of oncogenic human papillomavirus type 31 is not essential for early and late viral functions.
Stubenrauch F, Colbert A, Laimins L
J Virol. 1998; 72(10):8115-23.
PMID: 9733852
PMC: 110149.
DOI: 10.1128/JVI.72.10.8115-8123.1998.
Transactivation-competent bovine papillomavirus E2 protein is specifically required for efficient repression of human papillomavirus oncogene expression and for acute growth inhibition of cervical carcinoma cell lines.
Goodwin E, Naeger L, Breiding D, Androphy E, DiMaio D
J Virol. 1998; 72(5):3925-34.
PMID: 9557678
PMC: 109618.
DOI: 10.1128/JVI.72.5.3925-3934.1998.